Works matching IS 00071048 AND DT 2021 AND VI 192 AND IP 6
Results: 33
Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1‐mutated acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1054, doi. 10.1111/bjh.17347
- By:
- Publication type:
- Article
Conditioning intensity before allogeneic haematopoietic stem cell transplantation: a quality control audit.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. e151, doi. 10.1111/bjh.17369
- By:
- Publication type:
- Article
Phase I study of F16IL2 antibody–cytokine fusion with very low‐dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. e148, doi. 10.1111/bjh.17365
- By:
- Publication type:
- Article
Cognitive performance as a predictor of healthcare transition in sickle cell disease.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1082, doi. 10.1111/bjh.17351
- By:
- Publication type:
- Article
Flow cytometry reveals the nuances of clonal haematopoiesis.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 949, doi. 10.1111/bjh.17348
- By:
- Publication type:
- Article
MgSO<sub>4</sub> anticoagulant prevents pseudothrombocytopenia by preserving the integrity of the platelet GPIIb‐IIIa complex.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. e144, doi. 10.1111/bjh.17298
- By:
- Publication type:
- Article
Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1100, doi. 10.1111/bjh.17266
- By:
- Publication type:
- Article
Rearrangements of ATP5L‐KMT2A in acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. e139, doi. 10.1111/bjh.17265
- By:
- Publication type:
- Article
The heparin‐von Willebrand factor interaction and conventional tests of haemostasis – the challenges in predicting bleeding in cardiopulmonary bypass.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1073, doi. 10.1111/bjh.17263
- By:
- Publication type:
- Article
Myeloma clinical outcomes following the first wave of COVID‐19: results from the Thames Valley Cancer Alliance (UK).
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. e136, doi. 10.1111/bjh.17261
- By:
- Publication type:
- Article
Massive pneumomediastinum due to perforated pneumatosis cystoides in graft‐versus‐host disease.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 948, doi. 10.1111/bjh.17253
- By:
- Publication type:
- Article
A very rare complication of subdural haematoma: fibrin‐associated diffuse large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 947, doi. 10.1111/bjh.17239
- By:
- Publication type:
- Article
von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate‐to‐severe COVID‐19 patients.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1097, doi. 10.1111/bjh.17216
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1106, doi. 10.1111/bjh.17114
- Publication type:
- Article
Paradoxical effect of SARS‐CoV‐2 infection in patients with immune thrombocytopenia.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 973, doi. 10.1111/bjh.17077
- By:
- Publication type:
- Article
The effect of 5‐azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 978, doi. 10.1111/bjh.17062
- By:
- Publication type:
- Article
Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy‐free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK).
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1031, doi. 10.1111/bjh.17045
- By:
- Publication type:
- Article
Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 997, doi. 10.1111/bjh.17044
- By:
- Publication type:
- Article
Cytoreductive treatment in patients with CALR‐mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 988, doi. 10.1111/bjh.16988
- By:
- Publication type:
- Article
Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1049, doi. 10.1111/bjh.16946
- By:
- Publication type:
- Article
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1068, doi. 10.1111/bjh.16865
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 943, doi. 10.1111/bjh.16826
- Publication type:
- Article
Neuro‐meningeal relapse in anaplastic large‐cell lymphoma: incidence, risk factors and prognosis – a report from the European intergroup for childhood non‐Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1039, doi. 10.1111/bjh.16755
- By:
- Publication type:
- Article
The 5‐year follow‐up of a real‐world observational study of patients in the United Kingdom and Ireland receiving ibrutinib for relapsed/refractory mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1035, doi. 10.1111/bjh.16739
- By:
- Publication type:
- Article
The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1092, doi. 10.1111/bjh.16724
- By:
- Publication type:
- Article
Molecular and clinical features of myeloid neoplasms with somatic DDX41 mutations.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1006, doi. 10.1111/bjh.16668
- By:
- Publication type:
- Article
Post‐haematopoietic cell transplantation outcomes: why ST2 became a 'golden nugget' biomarker.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 951, doi. 10.1111/bjh.16497
- By:
- Publication type:
- Article
Clonal relationship in multisited mucosa‐associated lymphoid tissue lymphomas: a single‐centre experience.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1020, doi. 10.1111/bjh.16717
- By:
- Publication type:
- Article
Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low‐intensity chemotherapy in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1026, doi. 10.1111/bjh.16722
- By:
- Publication type:
- Article
Emergency response to radiological and nuclear accidents and incidents.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 968, doi. 10.1111/bjh.16138
- By:
- Publication type:
- Article
Long‐term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high‐dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1011, doi. 10.1111/bjh.16714
- By:
- Publication type:
- Article
Prognostic indices in diffuse large B‐cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R‐CHOP 14 versus 21 phase 3 trial.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1015, doi. 10.1111/bjh.16691
- By:
- Publication type:
- Article
Estimating a normal reference range for serum B‐cell maturation antigen levels for multiple myeloma patients.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1064, doi. 10.1111/bjh.16673
- By:
- Publication type:
- Article